PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)

被引：0
|
作者：
Cereda, S.
Mazza, E.
Passoni, P.
Nicoletti, R.
Balzano, G.
Zerbi, A.
Staudacher, C.
di Carlo, V
Reni, M.
机构：
[1] San Raffaele Sci Inst, Dept Oncol, I-20132 Milan, Italy
[2] San Raffaele Sci Inst, Dept Radiotherapy, I-20132 Milan, Italy
[3] San Raffaele Sci Inst, Dept Radiol, I-20132 Milan, Italy
[4] San Raffaele Sci Inst, Dept Surg, I-20132 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：58 / 59
页数：2
相关论文
共 50 条
  • [1] PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Vitali, G.
    Passoni, P.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V
    Reni, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI50 - XI50
  • [2] Weekly Epirubicin as Salvage Therapy in Patients with Gemcitabine-Resistant Advanced Pancreatic Cancer
    Cereda, S.
    Rognone, A.
    Mazza, E.
    Fugazza, C.
    Ceraulo, D.
    Villa, E.
    Reni, M.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 698 - 700
  • [3] SALVAGE THERAPY WITH MITOMYCIN AND IFOSFAMIDE (MI) IN PATIENTS WITH GEMCITABINE-RESISTANT METASTATIC PANCREATIC CANCER
    Cereda, S.
    Ghidini, M.
    Passoni, P.
    Rognone, A.
    Fugazza, C.
    Ceraulo, D.
    Mazza, E.
    Nicoletti, R.
    Villa, E.
    Reni, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 186
  • [4] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 113 - 123
  • [5] Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    M Reni
    L Pasetto
    G Aprile
    S Cordio
    E Bonetto
    S Dell'oro
    P Passoni
    L Piemonti
    C Fugazza
    G Luppi
    C Milandri
    R Nicoletti
    A Zerbi
    G Balzano
    V Di Carlo
    A A Brandes
    British Journal of Cancer, 2006, 94 : 785 - 791
  • [6] Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    Reni, M
    Pasetto, L
    Aprile, G
    Cordio, S
    Bonetto, E
    Dell'Oro, S
    Passoni, P
    Piemonti, L
    Fugazza, C
    Luppi, G
    Milandri, C
    Nicoletti, R
    Zerbi, A
    Balzano, G
    Di Carlo, V
    Brandes, AA
    BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 785 - 791
  • [7] Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial
    Cereda, Stefano
    Reni, Michele
    Rognone, Alessia
    Fugazza, Clara
    Ghidini, Michele
    Ceraulo, Domenica
    Brioschi, Matteo
    Nicoletti, Roberto
    Villa, Eugenio
    CHEMOTHERAPY, 2011, 57 (02) : 156 - 161
  • [8] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (03): : 288 - 289
  • [9] In Response to 'Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?'
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (03): : 290 - 290
  • [10] Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer
    Bayoglu, Ibrahim Vedat
    Varol, Umut
    Yildiz, Ibrahim
    Muslu, Ugur
    Alacacioglu, Ahmet
    Kucukzeybek, Yuksel
    Akyol, Murat
    Demir, Lutfiye
    Dirican, Ahmet
    Cokmert, Suna
    Yildiz, Yasar
    Karabulut, Bulent
    Uslu, Ruchan
    Tarhan, Mustafa Oktay
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (17) : 7119 - 7123
12345